• Corpus ID: 34869202

Cost-sharing : Effects on spending and outcomes

  title={Cost-sharing : Effects on spending and outcomes},
  author={Brian C Quinn and Jon B. Christianson and N. Farag and Sarah Goodell and John F. Hoadley and Haiden A. Huskamp and Frank Levy and Joseph P Newhouse},

Figures and Tables from this paper

A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health
It is probable that health services use could decrease with universal pharmacare among those who gain drug insurance, and cross-price effects of extending drug coverage should be included in costing simulations.
Who Benefits from the Fixed Copayment of Medical and Pharmaceutical Expenditure among the Korean Elderly?
  • Eunjae Park, S. Choi
  • Medicine, Political Science
    International journal of environmental research and public health
  • 2020
The study shows that cost sharing changes affect Korean patients with different income levels in different ways, and there was a significant increase in outpatient visits among individuals with lower income in the case group.
Heterogeneous Effects of Health Insurance on Birth Related Outcomes: Unpacking Compositional vs. Direct Changes
Comparing birth related outcomes for those aged 24-25 years after the law, to outcomes among older young adults shows that since the law subsidized contraceptives mainly among higher socioeconomic groups, the composition of mothers shifted towards less advantaged groups.
Association of daily copayments with use of hospital care among medicare advantage enrollees
Instituting per-diem copayments was associated with reductions in number of admissions and hospital stays, but not length of stay once admitted, and effects of inpatient cost-sharing changes were magnified for persons with greater baseline use of hospital care.
Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan
An increase in pharmacy retail prices as the major driver for higher co-payments is suggested and it is recommended that Kyrgyzstan should introduce medicine price regulation and exemptions for low-income people from co- payments to ensure a more affordable and equitable access to medicines.
Effective healthcare cost containment policies. Using the Netherlands as a case study
It is found that certain important cost drivers such as wages and capital are being sparsely covered in countries with public provision of health care, as well as for the US system.
Does prescriptive appropriateness reduce health expenditure ? Main effects and some unintended outcomes
Overall, a remarkable reduction in both outpatients’ spending and volumes after the introduction of the “appropriateness” decree is found, suggesting that the policy was effective in containing health costs.
Effects of Caps on Cost Sharing for Skilled Nursing Facility Services in Medicare Advantage Plans
To evaluate a federal regulation effective in 2011 that limited how much that Medicare Advantage (MA) plans could charge for the first 20 days of care in a skilled nursing facility (SNF).
Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans
The elimination of cost sharing for screening mammography under the ACA was associated with an increase in rates of use of this service among older women for whom screening is recommended and was attenuated among women living in areas with lower educational attainment and was negligible among Hispanic women.
The Role of Medicare's Inpatient Cost‐Sharing in Medicaid Entry
Increasing Medicare cost-sharing requirements may promote Medicaid enrollment among low-income beneficiaries and potential savings from an increased cost- sharing in the Medicare program may be offset by increased Medicaid participation.


Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
Pharmacy benefit design represents an important public health tool for improving patient treatment and adherence and increased cost sharing is highly correlated with reductions in pharmacy use, but the long-term consequences of benefit changes on health are still uncertain.
Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.
Although many obstacles exist, varying copayments for CL therapy by therapeutic need would reduce hospitalizations and ED use--with total savings of more than 1 billion dollars annually.
Health savings accounts and health care spending.
The findings are consistent with the notion that CDHP benefit designs affect decisions that are at the discretion of the consumer, such as whether to fill or refill a prescription, but have less effect on care decisions that is more at the mercy of the provider.
Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
Increased cost-sharing for prescription drugs in elderly persons and welfare recipients was followed by reductions in use of essential drugs and a higher rate of serious adverse events and ED visits associated with these reductions.
Patient Cost-Sharing and Hospitalization Offsets in the Elderly.
It is found that physician visits and prescription drug usage have elasticities that are similar to those of the RAND Health Insurance Experiment (HIE), however, it is not found that substantial "offset" effects in terms of increased hospital utilization are found.
Family Foundation, Health Research & Educational Trust
  • Employer Health Benefits: 2010 Annual Survey,
  • 2010
Evidence that value-based insurance can be effective.
An examination of one value-based insurance design program found that the program led to reduced use of nondrug health care services, offsetting the costs associated with additional use of drugs encouraged by the program.
Health status and heterogeneity of cost-sharing responsiveness: how do sick people respond to cost-sharing?
It is shown empirically that cost-sharing responsiveness does differ by health status using data from the Medicare Current Beneficiary Survey and a test is developed to demonstrate that adjusting the results for selection bias would result in estimates of greater heterogeneity.
Emergency department use and subsequent hospitalizations among members of a high-deductible health plan.
Traditional health plan members who switched to high-deductible coverage visited theEmergency department less frequently than controls, with reductions occurring primarily in repeat visits for conditions that were not classified as high severity, and had decreases in the rate of hospitalizations from the emergency department.